Daniel Lynch, Director at bluebird bio, Inc. (BLUE), sold 2,000 shares at $77.37 ($157K) on 2017-02-24, disclosed to the SEC on 2017-02-28.
Open-market sale of $157k BLUE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $77.37 | 1,000 | $77K | 49.2% |
| 2 | $80.00 | 1,000 | $80K | 50.8% |
| Total | $78.69 avg | 2,000 | $157K | 100% |
| Filing → |
| SWTX | SELL | 2025-02-12 | $15.4M | — | Filing → |
| BPMC | SELL | 2018-02-16 | $1.0M | — | Filing → |
| BPMC | SELL | 2018-02-14 | $2.6M | — | Filing → |